Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome Annotation and Assembly03:36

Genome Annotation and Assembly

19.6K
The genome refers to all of the genetic material in an organism. It can range from a few million base pairs in microbial cells to several billion base pairs in many eukaryotic organisms. Genome assembly refers to the process of taking the DNA sequencing data and putting it all back together in a correct order to create a close representation of the original genome. This is followed by the identification of functional elements on the newly assembled genome, a process called genome annotation.
19.6K
RNA-seq03:21

RNA-seq

10.6K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.6K
Improving Translational Accuracy02:07

Improving Translational Accuracy

12.0K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
12.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAE-UNETR++: Masked Autoencoder Pretraining for 3-D Lung Nodule Segmentation.

bioRxiv : the preprint server for biology·2026
Same author

Evolutionary and Functional Analysis of Caspase-8 and ASC Interactions to Drive Lytic Cell Death, PANoptosis.

Molecular biology and evolution·2025
Same author

Bayesian identification of differentially expressed isoforms using a novel joint model of RNA-seq data.

PLoS computational biology·2025
Same author

SPARC: Structural properties associated with residue constraints.

Computational and structural biotechnology journal·2022
Same author

Identifying Function Determining Residues in Neuroimmune Semaphorin 4A.

International journal of molecular sciences·2022
Same author

Correction to: A survey of TIR domain sequence and structure divergence.

Immunogenetics·2022

Related Experiment Video

Updated: Oct 21, 2025

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms
10:41

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

9.4K

A Bayesian approach for accurate de novo transcriptome assembly.

Xu Shi1, Xiao Wang1, Andrew F Neuwald2

  • 1Bradley Department of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, 900 North Glebe Road, Arlington, VA, 22203, USA.

Scientific Reports
|September 4, 2021
PubMed
Summary

BayesDenovo improves transcriptome assembly accuracy from RNA-seq data by reconstructing splicing graphs and estimating transcript expression. This novel approach reduces errors, especially for complex genes, and identifies cancer-related transcripts.

More Related Videos

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.5K
Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.3K

Related Experiment Videos

Last Updated: Oct 21, 2025

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms
10:41

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved Non-model Organisms

Published on: May 9, 2017

9.4K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.5K
Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.3K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • De novo transcriptome assembly from massive RNA-seq data presents challenges due to alternative splicing and variable gene expression.
  • Existing assembly methods often produce inaccurate or mis-assembled transcripts, particularly for complex gene structures.

Purpose of the Study:

  • To develop a robust and accurate de novo transcriptome assembler for RNA-seq data.
  • To address the limitations of current assemblers in handling alternative splicing and expression levels.
  • To identify phenotype-specific transcripts relevant to diseases like breast cancer.

Main Methods:

  • Employs a read-guided strategy to reconstruct accurate splicing graphs from RNA-seq data.
  • Utilizes a Bayesian strategy to estimate transcript expression probabilities without penalizing low-expression transcripts.
  • Validated through simulation studies and benchmark tests on cell line data.

Main Results:

  • BayesDenovo significantly reduces false positives and enhances assembly accuracy compared to other assemblers.
  • Demonstrates superior performance for alternatively spliced genes and transcripts with varying expression levels.
  • Shows increased robustness across multiple replicates, assembling a greater proportion of common transcripts.
  • Identified phenotype-specific transcripts associated with breast cancer recurrence in clinical data.

Conclusions:

  • BayesDenovo offers a highly accurate and robust solution for de novo transcriptome assembly.
  • The method effectively handles challenges posed by alternative splicing and expression variability.
  • Its application in cancer genomics can reveal novel disease-associated transcripts.